A Randomised Phase II Study to Investigate the Feasibility and Benefits of Combining ZD1839 and Cisplatin/5FU [fluorouracil], as Induction Therapy, in Patients With Locally and Advanced Squamous Cell Carcinoma of the Head and Neck.
Phase of Trial: Phase II
Latest Information Update: 12 May 2009
At a glance
- Drugs Cisplatin; Fluorouracil; Gefitinib
- Indications Head and neck cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 26 Nov 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 24 Mar 2006 New trial record.